| Nicolas R Eller, PA-C | |
|
8200 Dodge St, Omaha, NE 68114-4113 | |
| (402) 955-7400 | |
| (402) 955-7405 |
| Full Name | Nicolas R Eller |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant - Surgical |
| Location | 8200 Dodge St, Omaha, Nebraska |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093387649 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363AS0400X | Physician Assistant - Surgical | 2631 (Nebraska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Nicolas R Eller, PA-C Po Box 24607, Omaha, NE 68124-0607 Ph: (402) 955-5400 | Nicolas R Eller, PA-C 8200 Dodge St, Omaha, NE 68114-4113 Ph: (402) 955-7400 |
News Archive
A breakthrough in understanding a mother's immune response during pregnancy suggests a new direction for treating autoimmune diseases.
A new paper published by McGill University researchers in JAMA Internal Medicine suggests that some clinical trials may promote the use of ineffective and costly treatments. That's the opposite of what clinical trials are aimed at, namely preventing ineffective and costly treatments from being taken up by physicians and patients.
Cardiologists at The Ohio State University Wexner Medical Center are the first in the United States to test a new type of ablation technology for patients suffering from atrial fibrillation, a common type of irregular heartbeat.
Resistance-based interval exercise helps improve endothelial function—including blood flow and blood vessel dilation—both in older adults with type 2 diabetes and in age-matched non-exercisers and regular exercisers, according to new research published in the American Journal of Physiology—Heart and Circulatory Physiology.
New data from the IDEAL-LM trial found that a biodegradable polymer everolimus-eluting stent (BP-EES) followed by four months of dual antiplatelet therapy (DAPT) was safe and effective compared to a conventional durable polymer everolimus-eluting stent (DP-EES) followed by 12 months of DAPT in patients undergoing PCI for unprotected left main coronary artery (uLMCA) disease.
› Verified 9 days ago
Neil C Jouvenat Ii, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 4242 Farnam St Ste 650, Omaha, NE 68131 Phone: 402-559-8600 | |
Jennifer M Vaughn, PA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 601 N 30th St, Omaha, NE 68131 Phone: 402-449-4590 | |
Karen R Schrader, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 988102 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-4015 Fax: 402-559-8715 | |
Bridget A Burke, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 988102 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-8000 Fax: 402-559-8746 | |
Ms. Robbie L Lane, P.A.-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 8111 Dodge St, Suite 237, Omaha, NE 68114 Phone: 402-354-5210 | |
Mr. Ray Everett Skelton, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 987400 Nebraska Medical Center, Omaha, NE 68198 Phone: 402-559-7592 | |
Kimberly Mccolley, P.A.-C. Physician Assistant Medicare: May Accept Medicare Assignments Practice Location: Emile @ 42nd St, Omaha, NE 68198 Phone: 402-559-4015 Fax: 402-559-8715 |